Similar Articles
1431 First multicenter study for risk factors for hepatocellular carcinoma development in North Africa
1432 Hepatocellular carcinoma xenograft supports HCV replication: A mouse model for evaluating antivirals
1433 Splenic infarction associated with sorafenib use in a hepatocellular carcinoma patient
1434 Surgical vs percutaneous radiofrequency ablation for hepatocellular carcinoma in dangerous locations
1435 Promoter polymorphism of MRP1 associated with reduced survival in hepatocellular carcinoma
1436 Hepatocellular carcinoma treated with transarterial chemoembolization: Dynamic perfusion-CT in the assessment of residual tumor
1437 Leptin in hepatocellular carcinoma
1438 Hepatic blood inflow occlusion without hemihepatic artery control in treatment of hepatocellular carcinoma
1439 Transarterial embolization ablation of hepatocellular carcinoma with a lipiodol-ethanol mixture
1440 Fresh frozen plasma transfusion does not affect outcomes following hepatic resection for hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA